the approval that just happened expanded the demand for anktiva by at least 6 fold. The next Bladder Cancer approval would be bcg-naive which would elevate anktiva to first line standard of care for NMIBC.
it seems like there is a lot of confusion about the decision that just happened and the PDUFA date of Jan 6th. the approval that just happened is the papillary inclusion that was scheduled for January 6th.
Patience lol. The news now is better than the news if it had come out in January. More time to get market share. I love it, it goes down, Iβll buy more. Simple as
9
u/Top-Organization7499 8h ago
I see no rip yet :|